As of 2025-11-13, the Intrinsic Value of Eurobio Scientific SA (ALERS.PA) is 25.74 EUR. This ALERS.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 24.55 EUR, the upside of Eurobio Scientific SA is 4.90%.
The range of the Intrinsic Value is 17.65 - 52.63 EUR
Based on its market price of 24.55 EUR and our intrinsic valuation, Eurobio Scientific SA (ALERS.PA) is undervalued by 4.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 17.65 - 52.63 | 25.74 | 4.9% |
| DCF (Growth 10y) | 19.70 - 55.06 | 27.97 | 13.9% |
| DCF (EBITDA 5y) | 12.92 - 19.65 | 16.79 | -31.6% |
| DCF (EBITDA 10y) | 15.42 - 23.12 | 19.45 | -20.8% |
| Fair Value | 5.76 - 5.76 | 5.76 | -76.54% |
| P/E | 10.17 - 27.19 | 19.20 | -21.8% |
| EV/EBITDA | (5.45) - 25.33 | 7.67 | -68.8% |
| EPV | 33.64 - 49.49 | 41.56 | 69.3% |
| DDM - Stable | 2.06 - 8.63 | 5.34 | -78.2% |
| DDM - Multi | 5.87 - 19.67 | 9.10 | -62.9% |
| Market Cap (mil) | 251.64 |
| Beta | 0.29 |
| Outstanding shares (mil) | 10.25 |
| Enterprise Value (mil) | 241.53 |
| Market risk premium | 5.82% |
| Cost of Equity | 8.12% |
| Cost of Debt | 5.00% |
| WACC | 7.63% |